Eva Hellstrom-Lindberg: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Cobalt release from glazed earthenware: Observations in a case of lead poisoning

Anders I. Seldén, Carin Norberg, Christine Karlson-Stiber, Eva Hellström-Lindberg

Journal:

Environmental Toxicology and Pharmacology

Year:

2007

Language:

english

File:

PDF, 134 KB

english, 2007

2

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Svensson, Tobias, Chowdhury, Onima, Garelius, Hege, Lorenz, Fryderyk, Saft, Leonie, Jacobsen, Sten-Eirik, Hellström-Lindberg, Eva, Cherif, Honar

Journal:

European Journal of Haematology

Year:

2014

Language:

english

File:

PDF, 358 KB

english, 2014

3

Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells

Liu, Lisa L, Beziat, Vivien, Sheng, Vincent Oei Yi, Pfefferle, Aline, Schaffer, Marie, Lehmann, Soren, Hellstrom-Lindberg, Eva, Soderhall, Stefan, Heyman, Mats, Grander, Dan, Malmberg, Karl-Johan

Journal:

Cancer Immunology Research

Year:

2017

Language:

english

File:

PDF, 4.51 MB

english, 2017

4

Cost Effectiveness of Lenalidomide in the Treatment of Transfusion-Dependent Myelodysplastic Syndromes in the United States

Goss, Thomas F., Szende, Agota, Schaefer, Caroline, Totten, P. Jane, Knight, Robert, Jädersten, Martin, Hellström-Lindberg, Eva, List, Alan F.

Journal:

Year:

2006

Language:

english

File:

PDF, 430 KB

english, 2006

5

Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes

Dr. Per Boye Hansen, Hans E. Johnsen, Erik Hippe, Eva Hellström-Lindberg, Elisabeth Ralfkiaer

Journal:

American Journal of Hematology

Year:

1993

Language:

english

File:

PDF, 720 KB

english, 1993

6

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

Lewis R. Silverman, Pierre Fenaux, Ghulam J. Mufti, Valeria Santini, Eva Hellström-Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour

Journal:

Year:

2011

Language:

english

File:

PDF, 177 KB

english, 2011

7

Supportive care, growth factors, and new therapies in myelodysplastic syndromes

Eva Hellström-Lindberg, Luca Malcovati

Journal:

Year:

2008

Language:

english

File:

PDF, 245 KB

english, 2008

8

Significance of JAK2 and TET2 mutations in myelodysplastic syndromes

Eva Hellström-Lindberg

Journal:

Year:

2010

Language:

english

File:

PDF, 303 KB

english, 2010

9

Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes

John F. Seymour, Pierre Fenaux, Lewis R. Silverman, Ghulam J. Mufti, Eva Hellström-Lindberg, Valeria Santini, Alan F. List, Steven D. Gore, Jay Backstrom, David McKenzie, C.L. Beach

Journal:

Critical Reviews in Oncology/Hematology

Year:

2010

Language:

english

File:

PDF, 332 KB

english, 2010

10

Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes

Lars Göran Lundberg, Eva Hellström-Lindberg, Lena Kanter-Lewensohn, Richard Lerner, Jan Palmblad

Journal:

Leukemia Research

Year:

2006

Language:

english

File:

PDF, 193 KB

english, 2006

11

Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion

Pierre Fenaux, David Bowen, Norbert Gattermann, Eva Hellström-Lindberg, Wolf-Karsten Hofmann, Michael Pfeilstöcker, Guillermo Sanz, Valeria Santini

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 159 KB

english, 2010

12

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

Eva Hellström-Lindberg, Robert Negrin, Richard Stein, Sanford Krantz, Greger Lindberg, James Vardiman, ÅKe ÖSt, Peter Greenberg

Journal:

British Journal of Haematology

Year:

1997

Language:

english

File:

PDF, 427 KB

english, 1997

13

Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology

Eva Hellström-Lindberg, Lena Kanter-Lewensohn, Janet Nichol, Åke Öst, for the Scandinavian MDS Group, Sweden, Norway

Journal:

British Journal of Haematology

Year:

1999

Language:

english

File:

PDF, 297 KB

english, 1999

14

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life

Eva Hellström-Lindberg, Nina Gulbrandsen, Greger Lindberg, Tomas Ahlgren, Inger Marie S. Dahl, Ingunn Dybedal, Gunnar Grimfors, Eva Hesse-Sundin, Martin Hjorth, Lena Kanter-Lewensohn, Olle Linder, Mic

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 214 KB

english, 2003

15

Sixth International Symposium on Myelodysplastic Syndromes, Stockholm, June 14–17, 2001

Eva Hellström-Lindberg

Journal:

International Journal of Hematology

Year:

2002

Language:

english

File:

PDF, 50 KB

english, 2002

16

Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression

Gudrun Göhring, Aristoteles Giagounidis, Guntram Büsche, Hans Heinrich Kreipe, Martin Zimmermann, Eva Hellström-Lindberg, Carlo Aul, Brigitte Schlegelberger

Journal:

Annals of Hematology

Year:

2010

Language:

english

File:

PDF, 280 KB

english, 2010

17

Lead poisoning from souvenir earthenware

Eva Hellström-Lindberg, Andreas Björklund, Christine Karlson-Stiber, Pauline Harper, Anders I. Seldén

Journal:

International Archives of Occupational and Environmental Health

Year:

2006

Language:

english

File:

PDF, 203 KB

english, 2006

18

Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes

Andrea Pellagatti, Eva Hellström-Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, James S. Wainscoa

Journal:

British Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 360 KB

english, 2008

19

Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C

Pierre Fenaux, Norbert Gattermann, John F. Seymour, Eva Hellström-Lindberg, Ghulam J. Mufti, Ulrich Duehrsen, Steven D. Gore, Fernando Ramos, Odile Beyne-Rauzy, Alan List, David McKenzie, Jay Backstro

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 155 KB

english, 2010

20

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Paresh Vyas, Eva Hellström-Lindberg, James S. Wainscoat,

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 77 KB

english, 2011

21

Abstract: treatment of patients with myelodysplastic syndromes with G-CSF and erythropoietin

Eva Hellström-lindberg, Gunnar BirgegÅrd, Magnus Carlsson, Jan Carneskog, Inger-Marie Dahl, Ingunn Dybedal, Gunnar Grimfors, Karl Merk, Jon-Magnus Tangen, Ingemar Winqvist, Åke Öst, Anders Fasth, Gunn

Journal:

Medical Oncology

Year:

1993

Language:

english

File:

PDF, 500 KB

english, 1993

22

In vitro suspension culture reactions to 1,25 dihydroxyvitamin D3 in relation to bone marrow morphology and prognosis in patients with myelodysplastic syndromes

Eva Hellström-Lindberg, Karl-Henrik Robèrt, Birgitta Åhnsén, Annika Elmhorn-Rosenborg, Yvonne Kock, Åke Öst

Journal:

Leukemia Research

Year:

1992

Language:

english

File:

PDF, 647 KB

english, 1992

23

Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes

Birgitta Swolin, Inge Högh Kristiansen, Stig Rödjer, Eva Hellström-Lindberg

Journal:

Leukemia Research

Year:

1993

Language:

english

File:

PDF, 491 KB

english, 1993

24

Prediction of response to G-CSF and epo treatment for the anaemia of myelodysplastic syndromes (MDS)

Eva Hellström-Lindberg, Robert Negrin, Richard Stein, Sanford Krantz, James Vardiman, Åke Öst, Peter Greenberg

Journal:

Leukemia Research

Year:

1994

Language:

english

File:

PDF, 163 KB

english, 1994

25

A pharmacodynamic study of 5-azacytidine in the P39 cell line

Rasheed Khan, Anni Aggerholm, Peter Hokland, Moustapha Hassan, Eva Hellström-Lindberg

Journal:

Experimental Hematology

Year:

2006

Language:

english

File:

PDF, 475 KB

english, 2006

26

Hypomethylation and apoptosis in 5-azacytidine–treated myeloid cells

Rasheed Khan, Jan Schmidt-Mende, Mohsen Karimi, Vladimir Gogvadze, Moustapha Hassan, Tomas J. Ekström, Boris Zhivotovsky, Eva Hellström-Lindberg

Journal:

Experimental Hematology

Year:

2008

Language:

english

File:

PDF, 882 KB

english, 2008

27

New clues to the molecular pathogenesis of myelodysplastic syndromes

Martin Jädersten, Eva Hellström-Lindberg

Journal:

Experimental Cell Research

Year:

2010

Language:

english

File:

PDF, 576 KB

english, 2010

28

Freezing induces artificial cleavage of apoptosis-related proteins in human bone marrow cells

Jan Schmidt-Mende, Eva Hellström-Lindberg, Bertrand Joseph, Boris Zhivotovsky

Journal:

Journal of Immunological Methods

Year:

2000

Language:

english

File:

PDF, 158 KB

english, 2000

29

High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD

Jenny Lindahl, Eva Kimby, Bo Björkstrand, Birger Christensson, Eva Hellström-Lindberg

Journal:

Leukemia Research

Year:

2001

Language:

english

File:

PDF, 814 KB

english, 2001

30

Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

David T Bowen, Eva Hellstrom-Lindberg

Journal:

Leukemia Research

Year:

2001

Language:

english

File:

PDF, 45 KB

english, 2001

31

Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin

Eva Hellström-Lindberg, Lena Kanter-Lewensohn, Å Öst

Journal:

Leukemia Research

Year:

1997

Language:

english

File:

PDF, 1.07 MB

english, 1997

32

168 Low-dose chemotherapy in MDS

Eva Hellström-Lindberg

Journal:

Leukemia Research

Year:

1997

Language:

english

File:

PDF, 152 KB

english, 1997

33

152 Clinical results of the use of different cytokines in MDS

Eva Hellström-Lindberg

Journal:

Leukemia Research

Year:

1997

Language:

english

File:

PDF, 127 KB

english, 1997

34

Two pathways of apoptosis induced with all-trans retinoic acid and etoposide in the myeloid cell line P39

Zuzana Hassan, Bengt Fadeel, Boris Zhivotovsky, Eva Hellström-Lindberg

Journal:

Experimental Hematology

Year:

1999

Language:

english

File:

PDF, 916 KB

english, 1999

35

A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia

Eva Hellström-Lindberg, Karl-Henrik Robèrt, Gösta Gahrton, Greger Lindberg, Ann-Mari Forsblom, Yvonne Kock, Åke Öst

Journal:

British Journal of Haematology

Year:

1992

Language:

english

File:

PDF, 791 KB

english, 1992

36

Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry

Lena Kanter-Lewensohn, Eva Hellström-Lindberg, Yvonne Kock, Annika Elmhorn-Rosenborg, Åke öst

Journal:

European Journal of Haematology

Year:

1996

Language:

english

File:

PDF, 500 KB

english, 1996

37

Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine

Valeria Santini, Pierre Fenaux, Ghulam J. Mufti, Eva Hellström-Lindberg, Lewis R. Silverman, Alan List, Steven D. Gore, John F. Seymour, Jay Backstrom, Charles L. Beach

Journal:

European Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 103 KB

english, 2010

38

Octreotide for nausea and vomiting after chemotherapy and stem-cell transplantation

Gunhild Nordesjö-Haglund, Berit Lönnqvist, Greger Lindberg, Eva Hellstrôm-Lindberg

Journal:

Year:

1999

Language:

english

File:

PDF, 71 KB

english, 1999

39

Erythropoietins should be used according to guidelines

Matti S Aapro, Gunnar Birgegård, Carsten Bokemeyer, Paul Cornes, Jan Foubert, Pere Gascon, John Glaspy, Eva Hellström-Lindberg, Hartmut Link, Heinz Ludwig, Anders Österborg, Lazzaro Repetto, Pierre So

Journal:

The Lancet Oncology

Year:

2008

Language:

english

File:

PDF, 565 KB

english, 2008

40

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List, Steven D Gore, John F Seym

Journal:

The Lancet Oncology

Year:

2009

Language:

english

File:

PDF, 232 KB

english, 2009

41

Supportive Care and Use of Hematopoietic Growth Factors in Myelodysplastic Syndromes

Eva Hellström-Lindberg, Luca Malcovati

Journal:

Seminars in Hematology

Year:

2008

Language:

english

File:

PDF, 329 KB

english, 2008

42

Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes

Saft, Leonie, Björklund, Elisabet, Berg, Elisabeth, Hellström-Lindberg, Eva, Porwit, Anna

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 397 KB

english, 2013

43

Challenges of phase III trial design for novel treatments in diseases with no standard treatment: The AZA-001 myelodysplasia study model

Fenaux, Pierre, Seymour, John F., Santini, Valeria, Silverman, Lew, Gore, Steven, List, Alan, Sanz, Guillermo, Mufti, Ghulam J., Estey, Eli, Swern, Arlene S., Beach, C.L., Hellstrom-Lindberg, Eva

Journal:

Leukemia Research

Year:

2014

Language:

english

File:

PDF, 492 KB

english, 2014

44

Erythropoiesis stimulating agents and other growth factors in low-risk MDS

Hellström-Lindberg, Eva, van de Loosdrecht, Arjan

Journal:

Best Practice & Research Clinical Haematology

Year:

2013

Language:

english

File:

PDF, 240 KB

english, 2013

45

Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies

Hellström-Lindberg, Eva

Journal:

British Journal of Haematology

Year:

1995

Language:

english

File:

PDF, 402 KB

english, 1995

46

Erythropoiesis-stimulating agents in myelodysplastic syndromes

Hellström-Lindberg, Eva

Journal:

Leukemia and Lymphoma

Year:

2010

Language:

english

File:

PDF, 142 KB

english, 2010

47

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients

Bowen, David T., Hellström-Lindberg, Eva, Steensma, David P.

Journal:

British Journal of Haematology

Year:

2014

Language:

english

File:

PDF, 62 KB

english, 2014

48

Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q

Treppendahl, Marianne B., Möllgård, Lars, Hellström-Lindberg, Eva, Cloos, Paul, Grønbaek, Kirsten

Journal:

European Journal of Haematology

Year:

2013

Language:

english

File:

PDF, 134 KB

english, 2013

49

Low-Dose Ara-C in Myelodysplastic Syndromes (MDS) and Acute Leukemia Following MDS: Proposal for a Predictive Model

Hellström-Lindberg, Eva, Robèrt, Karl-Henrik, Gahrton, Gösta, Lindberg, Greger, Forsblom, Ann-Mari, Kock, Yvonne, Öst, Åke

Journal:

Leukemia and Lymphoma

Year:

1994

Language:

english

File:

PDF, 916 KB

english, 1994

50

Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes

Ryblom, Harriet, Hast, Robert, Hellström-Lindberg, Eva, Winterling, Jeanette, Johansson, Eva

Journal:

European Journal of Oncology Nursing

Year:

2015

Language:

english

File:

PDF, 401 KB

english, 2015